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The most prominent defence of the unicellular parasite Trypanosoma brucei against the host immune
system is a dense coat that comprises a variant surface glycoprotein (VSG). Despite the importance
of the VSG family, no complete structure of a VSG has been reported. Making use of high-resolution
structures of individual VSG domains, we employed small-angle X-ray scattering to elucidate the first
two complete VSG structures. The resulting models imply that the linker regions confer great flexibility
between domains, which suggests that VSGs can adopt two main conformations to respond to obstacles
and changes of protein density, while maintaining a protective barrier at all times. Single-molecule
diffusion measurements of VSG in supported lipid bilayers substantiate this possibility, as two freely
diffusing populations could be detected. This translates into a highly flexible overall topology of the
surface VSG coat, which displays both lateral movement in the plane of the membrane and variation
in the overall thickness of the coat.
Keywords: Membrane biophysics, Membrane trafficking, Parasite immune evasion, SAXS
The parasite Trypanosoma brucei thrives in the bloodstream
and tissue spaces of its mammalian host, where it is prone
to attack by the immune system. As a first defence against
the immune response, the bloodstream form of trypanosomes
is coated with a dense layer of variant surface glycoprotein
(VSG). This layer constitutes at least 95% of the cell-surface
proteins1,2 and impairs the identification of epitopes of invari-
ant surface proteins by the immune system3–6. Only a sin-
gle VSG gene is transcribed at any given time from a specific
genomic locus, the VSG expression site (ES). However, the
VSG itself is highly immunogenic and, once detected by the
immune system, antibodies specific for the expressed VSG
isoform will facilitate a rapid clearance of the infection7,8. To
establish a persistent infection, the parasite employs antigenic
variation to switch the expression to an antigenically distinct
VSG from a library that encodes several hundred VSGs9. This
continual switching forces the host immune system constantly
to chase novel antigen types. The shielding function that VSG
is thought to provide has been described only anecdotally and,
owing to a lack of a complete VSG structural model, the
mechanism remains unclear.
A further immune evasion strategy in T. brucei involves the
rapid clearing of antibodies bound to VSGs through passive
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sorting by hydrodynamic drag forces10. These forces push the
VSG–antibody complexes to the flagellar pocket, an invagina-
tion of the plasma membrane that spans approximately 5% of
the surface area of the pathogen. It is in this flagellar pocket
that all endo- and exocytosis takes place and the complexes
are rapidly internalized.
The VSGs analysed to date are homodimeric membrane
proteins with a total size of 100–120 kDa that are connected to
the outer leaflet of the plasma membrane by a glycosylphos-
phatidylinositol (GPI) anchor. VSG monomers consist of a
small C-terminal domain (CTD) that connects to the larger N-
terminal domain (NTD) via an unstructured region, Linker 1
(L1). This flexible linker is readily accessible to proteases,
which is highlighted by the fact that crystallization of purified
intact VSG regularly leads to crystals that contain only the
NTD11,12. VSG NTDs consist of 350–400 residues and are
grouped into two classes (type A and B) by the number and
position of conserved cysteine residues13,14. Although the se-
quences vary significantly between VSGs, the tertiary struc-
ture of NTDs is generally thought to be conserved, at least
within each type15,16. The central structural elements of the
NTD, derived from the structures of A-type VSGs MITat1.2
(M1.2) and ILTat1.24 (I1.24), are a coiled coil of approxi-
mately 10 nm length that is perpendicular to the cell mem-
brane, variable surface loops at the membrane distal end, an
antiparallel β -sheet and a set of short α-helices close to its C-
terminus. The CTD has been grouped into six classes (types
1–6) based on conserved sequence features13,17. Structural in-
formation of the type 2 CTD of M1.2 and the type 1 CTD of
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2I1.24 suggests that the VSG CTDs consist of one or two struc-
tured regions (S or S1 and S2) of 20–40 residues each flanked
by unstructured segments (L1 and L2)18,19. The structured re-
gions have a compact fold that consists of two short helices, a
short antiparallel β -sheet and an optional C-terminal α-helix.
We used small-angle X-ray scattering (SAXS) to combine
newly solved high-resolution domain structures of MITat1.1
(M1.1) to provide a model for the first experimentally de-
rived structure of a complete VSG. Additional SAXS experi-
ments on VSG I1.24 in combination with its published high-
resolution domain structures16,19 allowed a comparison be-
tween two complete VSGs, their overall architecture and the
structure–function relationship of the surface coat of T. brucei.
The results obtained by structural analyses were supported by
measuring the diffusion dynamics of VSG M1.1 in artificial
membranes.
Results
Crystal structure of the NTD of VSG M1.1. VSG M1.1
has an A-type NTD and a type 2 CTD, and is consequently
labelled an A2 VSG (Fig. 1a shows the domain composition).
Full-length M1.1 (sequence shown in Supplementary Fig. 1a)
was purified in its soluble form (sVSG) from trypanosome
cells by cleavage of the GPI anchor. In accordance with obser-
vations reported for M1.2 and I1.24, the CTD was not present
in the crystals, having presumably been cleaved off by the ac-
tion of endogenous proteases on the L1 region11,12 (Supple-
mentary Fig. 2).
Crystal-structure analysis (Supplementary Table 1) showed
that the NTD forms a homodimer (Fig. 1b). Central to the
structure of each monomer of the M1.1 NTD is a coiled coil
formed by two anti-parallel α-helices that span a distance of
9.4 nm (Fig. 1c). The coiled coil is flanked by shorter α-
helices that extend perpendicular to the central coil and repre-
sent the broadest part of the domain. This motif is 6.4 nm wide
in the dimer and is positioned at a vertical distance of 2.0 nm
from the C-terminal end of the domain. The structure close to
the N-terminal end forms variable surface loops that span an
area of 17 nm2 per dimer. Four conserved cysteine residues
form disulfide bonds between residues C15 and C145 and
residues C123 and C190 (Fig. 1b,c), which is consistent with
the configuration found in the NTDs of VSGs M1.4, M1.2 and
I1.24 (refs15,16,20). Distance-based similarity measures were
determined by superimposing M1.1 and M1.2 over 264 Cα
pairs and showed a low root mean squared deviation (r.m.s.d.)
of 0.9 Å, whereas superimposing M1.1 and I1.24 over 84 Cα
pairs led to an r.m.s.d. of 1.3 Å, despite sequence identities
of only 27.1% and 10.6%, respectively (all the values were
calculated with UCSF Chimera MatchMaker21). To high-
light the similarities and differences between these three VSG
NTD structures they are displayed in Supplementary Fig. 3a.
An oligosaccharide of the type (Man)n(GlcNAc)2 is linked to
residue N266 (Fig. 1b,c) with three mannose residues clearly
identified from the electron–density maps. An additional sig-
nal in the electron–density map for the inherently flexible
and heterogeneous oligosaccharide could not be resolved, but
a
N
C
b
L1 S
L2
G
NTD
CTD
*
*
*
*
c
7.5Å
K313
L316
L67
V49
K319
MAN403
C15/C145
C123/C190
FIG. 1. Crystal structure of the NTD of VSG M1.1. a, Schematic
overview of the domain architecture of the M1.1 dimer. In each
monomer the NTD is connected through L1 to the structured region
S of the CTD, which is in turn connected via L2 to the GPI anchor
G. Domains L1 through L2 form the CTD (bracket). b, The NTD of
M1.1 forms a rigid dimer (one monomer is coloured in dark blue and
the other in light blue). The oligosaccharide at N266 is highlighted in
red, the antiparallel β -sheet in orange and the disulfide-forming cys-
teines in yellow. c, One monomer of the M1.1 NTD coloured in a rain-
bow scheme from blue (N-terminus) to red (C-terminus). The struc-
ture includes a long coiled coil (blue, turquoise) encircled by shorter
α-helices near the C-terminal end (orange), a longer α-helix that con-
nects the NTD to the CTD (red) and variable surface loops near the
N-terminal end (green). The two cysteine pairs that form disulfide
bonds are marked with asterisks. The assignable part of the gly-
can, (Man)3(GlcNAc)2, which is covalently attached to residue N266,
is shown in yellow. Inset: a hydrophobic pocket is formed around L316
and is shielded by the oligosaccharide. The distance to the nearest
neighbouring surface residue K313 is 7.5 Å.
suggests the presence of a larger glycan, most probably a
(Man)4−9(GlcNAc)2 composition, which is common among
VSGs, for example, (Man)4(GlcNAc)2 in M1.2 (refs22–24).
The glycan is positioned above a hydrophobic pocket formed
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FIG. 2. Solution structure of the CTD of VSG M1.1. a, Amino acid sequence of the M1.1 CTD, residues S372 to S443, with the four conserved
cysteines highlighted in yellow and disulfide pairing indicated. The location of the experimentally determined secondary structure elements is
shown underneath the sequence (barrels for α-helices and arrows for β -strands). b, Overlay of residues Q376 to K417 of the 35 lowest-energy
structures (left) and the structure closest to the mean displayed as a ribbon diagram with disulfide bonds shown in yellow (right). c, Overlay of
residues Q376 to K426 of the 35 lowest-energy structures (left) and the structure closest to the mean displayed as a ribbon diagram with disulfide
bonds shown in yellow (right).
by V49, L67, L316 and K319 that is recessed by at least 7.5 Å
from the most proximate residue on the protein surface, K313
(Fig. 1c, inset).
Solution structure of the CTD of VSG M1.1. The CTD
used to elucidate the structure of VSG M1.1 was expressed
recombinantly. The polypeptide contained residues S372 to
S443 of the mature protein with an added glycine at the N-
terminus. This residue was a remnant from the removal of the
affinity tag used for purification (Supplementary Fig. 1a,b).
The 35 lowest-energy structures generated (Supplementary
Table 2) showed that the CTD structure is composed of two
α-helices separated by a turn and a short antiparallel β -sheet,
with two disulfide bonds between C387 and C405 and be-
tween C397 and C414 fixing these four secondary structure
elements into a compact arrangement (Fig. 2a,b). In addition
to this core structure, there is a short α-helix following the an-
tiparallel β -sheet (Fig. 2c). The C-terminal α-helix is defined
by its short-range nuclear Overhauser effect (NOE) pattern
and the positive (albeit small) heteronuclear NOE values, al-
though no long-range NOEs were observed between the core
structured region and this C-terminal α-helix. Consequently,
every calculated structure for M1.1 contains the C-terminal α-
helix, but the overlay of 35 structures clearly shows that this
helix is not anchored to the rest of the structure. The helix is
therefore locally ordered, but its position with respect to the
rest of the domain is not well defined (Fig. 2c). A compari-
son of the structure of the CTD of M1.1 with the previously
reported CTD structures of M1.2 and I1.24 (S1 domain only)
is shown in Supplementary Fig. 3b.
The structure of VSG M1.1 adopts two main conforma-
tions. SAXS of M1.1 sVSG was used to generate a low-
resolution molecular envelope for the complete molecule
(Supplementary Fig. 4c). This envelope was then used to
guide the placement of the high-resolution structures of the
NTD and CTD into a complete VSG structure. The CTD of
each monomer features a single structured domain S that is
connected to the NTD and the GPI anchor by the flanking un-
structured linkers L1 and L2, respectively (Fig. 1a). This is
the simplest CTD composition in T. brucei VSGs and repre-
sents a good starting point for the analysis of a complete VSG.
Rigid body modelling resulted in a set of four models with a
good fit to the experimental data, but with different spatial ar-
rangements of the CTD relative to the NTD (models in Fig. 3a
and Supplementary Figs 4 and 5). The distance spanned by
the two CTDs in a VSG dimer varies between 7.9 nm and
10.5 nm in the four models (Fig. 3a) with model 2 possess-
ing the greatest width. Consequently, its long axis of 14.1 nm
is smaller than the average of 15.5 nm for the other models
(Supplementary Table 3).
Superimposing the NTD of the four initial models displays
a shift in the placement of the CTD. The position of the CTD
varies by up to 121◦ along the interdomain axis for the repre-
sentative models (Fig. 4a and Supplementary Video 1), which
suggests that linker L1 confers interdomain freedom.
Not taking into account the hydration shell present on the
protein surface and presuming a rigid conformation, the area
a single VSG dimer theoretically occupies varies between at
least 25 nm2 and 31 nm2, allowing a total of 3.2− 4.0× 104
VSGs to fit into an area of 1 µm2(Supplementary Fig. 6 and
Supplementary Table 3). Assuming 144 µm2as the surface
area of a single cell2, the calculated values would amount to
4.6− 5.8× 106 VSGs per cell, which is in good agreement
with the published 5.7× 106 VSG dimers per cell25. How-
ever, these values assume a static protein equally distributed
on the cell surface and underestimate the actual area occupied
by VSGs. To account for the rotational freedom between the
CTD and the NTD as well as the rotational diffusion of the
protein on the cell surface, the circular area was calculated us-
ing the distance spanned by the two CTDs in the VSG dimer
with an added theoretical hydration layer of 1 nm as the diam-
eter. This results in a total area per VSG dimer of 77–123 nm2,
allowing 0.8−1.3×104 VSGs to diffuse freely in an area of
1 µm2, which corresponds to 1.2−1.9×106 VSG dimers per
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FIG. 3. Rigid-body models of two complete VSGs. a, Side and top-down view of four models (1–4) of VSG M1.1. The protein dimensions
parallel (width, W , and depth, D) and perpendicular (height, H) to the plane of the plasma membrane are displayed. The two monomers that
comprise each dimer are shown in light and dark blue. The N-glycan and GPI anchor are displayed in yellow. b, Side and top-down view of four
models (1–4) of VSG I1.24. The two monomers of each dimer are shown in light and dark red. Bar lengths are displayed according to the model
dimension.
parasite.
All the preceding M1.1 models were computed using two-
fold symmetry and with contact conditions for the N-terminal
dimer to approximate the restrictions conferred by the cell
membrane. To allow for the greater degree of freedom avail-
able for VSGs in solution, additional models were calculated
without specifying the symmetry of the protein or contact con-
ditions for the NTD. The resulting structures displayed cor-
rectly dimerized NTDs and an asymmetric conformation of
the CTD (Supplementary Fig. 4b). Although the CTD of
chain A extends in parallel to the symmetry axis, that of chain
B is tilted back towards the NTD.
The structure of VSG I1.24 also adopts two main confor-
mations. I1.24, like M1.2, possesses an A-type NTD, but
its CTD is of type 1. This is a more-complex type of CTD
composed of two structured regions S1 and S2. A flexible
linker (L1) connects the NTD to S1 with another such linker
(L2) that connects S1 to S2, which is directly connected to
the GPI anchor. To compare the influence of different types
of CTDs on the overall VSG structure, SAXS measurements
and rigid-body modelling of I1.24 were conducted in parallel
to M1.1. The CTD of I1.24 consists of 109 residues, com-
pared with the 75 residues of the M1.1 type 2 CTD. Previ-
ously published high-resolution data of the NTDs and CTDs
5b
121°
L1 90°
a
FIG. 4. Flexibility of linker L1 in VSG M1.1. a, The superimposed NTDs of models 1–4 of M1.1 demonstrate the flexibility of the CTD, which
varies in position along the interdomain axis by up to 121◦ facilitated through linker L1. Supplementary Video 1 gives a more detailed view of
the CTD localization. b, Top-down illustration of VSGs (blue) with a surface transmembrane protein (aquaporin 2 (PDB ID: 1FX8, red)) shown
to scale. The flexibility in linker L1 may allow the CTD to respond to obstacles, for example, transmembrane proteins, while the NTD position
remains unaffected.
of I1.24 (refs16,19) (ILTat1.24; Protein Database (PDB) ID:
2VSG and 2JWG, 2JWH) were used to deduce the complete
VSG structure, which resulted in four models (1–4) (Fig. 3b
and Supplementary Table 3). With a width of 9.7–11.0 nm,
I1.24 spans a slightly greater distance than M1.1, whereas the
average height is slightly shorter at 15.5 nm. However, both
proteins show similar compact and extended conformations.
The area spanned by the I1.24 dimers ranges from 25 nm2 to
35 nm2 for non-hydrated static models, which could form a
coat composed of 2.9−4.0×104 VSG dimers per square mi-
crometre. The circular area occupied by I1.24 is calculated
from the maximum width of the hydrated protein and spans
107− 133 nm2. This corresponds to 0.8− 0.9× 104 VSGs
µm−2. Compared with M1.1, 10− 31% fewer I1.24 VSG
molecules are required to pack the cell surface densely.
Two distinguishable freely diffusing populations of VSG
M1.1 are observed in supported lipid bilayers. The above
SAXS experiments were performed on VSGs in solution, in
which the proteins experience fewer constraints than when
anchored to the plasma membrane. As changes in the con-
formation of the VSG protein might well manifest them-
selves as differences in diffusion behaviour, we performed
single-molecule diffusion experiments on membrane-bound
VSG M1.1. A well-defined solid-supported lipid bilayer sys-
tem that guaranteed a uniform membrane composition and the
presence of only one protein species, the membrane form of
M1.1 (Supplementary Fig. 7), was chosen (Methods).
In addition, the low concentration of proteins (0.0897±
0.0003 µm−2) used in this experiment ensured diffusion mea-
surements of single M1.1 mfVSG molecules. The quality
of the lipid bilayer was validated by analysing the diffu-
sion of individual lipids. After excluding data that showed
non-Brownian statistics from the 1,890 lipid traces acquired
(minimum and average trace length of nine and 13, respec-
tively), a single lipid population that exhibited Brownian mo-
tion was found. A diffusion constant of Dlipids = 2.688±
0.005 µm2 s−1 was obtained from time averaging (Methods).
The uncertainty here and henceforth is the standard error, un-
less stated otherwise.
Next, the diffusive behaviour of individual VSG molecules
was measured. A total of 2,969 trajectories were collected,
with a minimum and average trace length of 20 and 49, re-
spectively.
Non-Gaussian stretches of protein trajectories were filtered
and excluded from analysis. The immobile fraction of the
VSG was in the same order of magnitude as for the lipids
(Supplementary Fig. 8).
All the remaining traces performed Brownian motion, with
separate mean square step lengths and variance (brown and
green in Fig. 5a, and Supplementary Fig. 9). Two families
clearly separated with the ratio of likelihoods to belong to
either family used as an additional sorting criterion. Fol-
lowing this grouping into families of slow (3.54%) and fast
(96.46%) traces (Fig. 5b), probability distributions of the dif-
fusion coefficients were generated by independently fitting the
time evolution of mean square displacement for each trace
(Fig. 5c). The average over the ensemble of these diffusion
coefficients provided the mean coefficients for fast and slow
diffusion, which were 2.87±0.03(1.08) µm2 s−1 and 0.81±
0.05(0.3) µm2 s−1, respectively. The numbers in brackets
comprise the width or standard deviation of the distribu-
tion. As expected for Brownian diffusion, these results corre-
sponded well to the diffusion coefficients obtained from time
averaging, in which a single mean square displacement curve
was constructed from concatenated trajectories. Here, the re-
spective diffusion coefficients were 2.716± 0.005 µm2 s−1
and 0.848± 0.002 µm2 s−1 (Fig. 5c). Notably, the diffusion
of the fast family was very similar to the diffusion of the lipids.
The overall statistical analysis performed here shows that
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FIG. 5. Diffusion behaviour of mfVSG M1.1 incorporated into a solid supported lipid bilayer. a–c, Analysis of single-molecule diffusion data
reveals a small population (3.54%) of slowly diffusive proteins (brown) and a large population (96.46%) that is significantly faster (green). a, The
square of measured step lengths (775 in total) as a function of time in a representative set of 32 traces associated with fast and slow processes,
after filtering for Brownian diffusion. Individual traces are separated by purple dots on the abscissa. The mean square step length is indicated
with a dashed-red (fast) and dashed-black (slow) line. b, Scatter plot that shows the separation of traces into two populations. Each of the 1,602
traces is represented by a point given by the mean square step length in the trace (abscissa), and the ratio of likelihoods for a trace to belong
to the fast and the slow diffusing population (ordinate). The mean square step lengths for the two populations are indicated with vertical dashed
lines. The horizontal dashed line indicates equal likelihood. c, A histogram that displays the distribution of diffusion coefficients for the population
of fast and slow proteins shown in b. The inset shows the mean square displacement as a function of time, calculated from the cumulative trace
of the two populations. Every fifth lag-time point is displayed. Error bars are standard errors. The mean diffusion coefficients are indicated by
arrows. The data displayed in b and c are representative of five technical replica measurements.
two distinct populations of proteins exist in the membrane.
Both families exhibited Brownian diffusion with coefficients
that were in the same order of magnitude. These diffusion
coefficients are, however, significantly distinct, which is re-
flective of our structural findings that two major VSG confor-
mations exist.
Discussion
In the present study, we solved the tertiary structure of the
NTDs and CTDs of a third VSG, M1.1 (A2 VSG), which is
largely in agreement with the previously reported structures
of M1.2 (A2 VSG) and I1.24 (A1 VSG). We also report the
complete structures of two VSGs that were obtained by com-
bining the high-resolution X-ray crystal structures of the NTD
and the high-resolution NMR structures of the CTD with low-
resolution SAXS experimental data. SAXS measurements are
performed with proteins in solution, in which the molecules
can freely adopt a variety of conformations. Under these con-
ditions, they do not experience the geometric constraints im-
posed, for example, by GPI anchoring into the plane of a two-
dimensional (2D) membrane space. The constraints enforced
on the dimeric protein by dimerization of the NTD, on the
one hand, and insertion of the lipid moiety of the GPI an-
chor into the membrane, on the other hand, suggest that the
two CTDs in the dimer must adopt similar conformations. We
therefore computed our models in two ways: (1) without re-
straints, which mimics the conditions found in solution, and
(2) by defining a two-fold symmetry of the VSG as an ap-
proximation of the conditions found when naturally anchored
to the lipid membrane. Structures obtained using this filtering
step are a subset of the possible conformations in solution. All
the models generated using these two approaches reassuringly
showed a dimerized NTD. The CTDs of a dimer in the models
generated without filtering for symmetric VSGs could, how-
ever, position asymmetrically (Supplementary Fig. 4b). This
result emphasizes the high degree of flexibility of the VSG,
which is mediated by linker L1. Filtering for conformations
that conform to the restraints imposed on the molecule when
anchored to the membrane resulted in models in which the
CTDs and GPI anchors fold towards the presumed membrane
location. This means that the environment of the VSG when
bound to the membrane significantly contributes to the overall
VSG structure. The flexibility conferred by L1 is evident here,
too, from the different conformations a symmetrical VSG can
adopt. These can be grouped into two main folds. One fold
is extended and slim (compact conformation), and the other
extends less from the membrane and has a wider footprint (re-
laxed conformation) (Fig. 6). The individual SAXS models
generated for one VSG differ by up to 30% in the area they oc-
cupy. This variance does not contradict a conserved structure–
function relationship because it is true for the model pool of
both the analysed VSGs. Instead, we propose that these in-
dividual models display conformations that can alter dynami-
cally in response to changes in the overall protein density on
the membrane. This hypothesis is supported by the presence
of two freely diffusing populations of VSG in an artificial lipid
bilayer system. This may allow the protein to adapt its struc-
ture to remain functional under different environmental con-
ditions encountered both on the cell surface and when present
in intracellular compartments during recycling26,27.
Antigenic variation replaces an old VSG with a new one.
The present data suggest that individual VSGs may occupy
a range of different surface areas on the plasma membrane.
However, the shielding function of the VSG must not be com-
promised at any time. Here the flexible conformations of the
VSGs, which allow an adaptation to a range of different pro-
tein densities, may extend the protein’s capability to function
in different environmental conditions. We suggest that con-
760 Å
14
0 
Å40 Å
15
5 Å
Compact Relaxed
FIG. 6. VSG packing on the cell surface. Side-view illustration of membranes occupied by VSGs at two different densities. The conformation
of tightly packed VSGs (left) can elevate the VSG above the transmembrane proteins (dark blue, red), whereas the relaxed conformation (right)
could allow the maintenance of a protective coat on the cell surface even at a reduced protein density.
tinuous transient variation between the two main VSG con-
formers could compensate for such natural fluctuations and
imprecisions, and provide robustness through structure to the
VSG function.
We have previously examined the maximum protein den-
sity of the VSG coat28,29. The simultaneous activation of
two independent VSGs in transgenic trypanosomes leads to an
overexpression of up to 150% of the total VSG30, which may
force all VSGs to adapt a compact conformation. The removal
of the C-terminal oligosaccharide drastically reduced the late-
ral mobility of VSG M1.6 in artificial bilayers29. This work
on VSG dynamics also showed that the natural VSG density
in a defined membrane can be increased by approximately
40–50% before the molecular crowding threshold (MCT) is
reached and the diffusion coefficient and mobile fraction of
the coat break down. We suggest that additional VSG on the
membrane results in a conformational change towards a com-
pact conformation and that only once all the VSG molecules
have adopted a compact state does the surface coat reach its
spatial limitations and the mobility collapses on a further in-
crease of protein density. This MCT-dependent collapse is
probably connected to protein deformations beyond the nor-
mal range of conformations. In the SAXS experiments re-
ported here, the VSG was not in such a highly crowded envi-
ronment.
Although VSGs dominate the trypanosome cell surface,
they are not the only proteins to populate the plasma mem-
brane. Like all eukaryotes, trypanosomes rely on receptors
and channels for nutrient uptake, sensing and communication.
These invariant transmembrane proteins may affect the free
diffusion of VSGs. High mobility, however, is essential for
VSG coat function. We suggest that the compact form of the
VSG lifts the protein well above the membrane and allows
floating over, for example, channels and receptors up to the
size of a G-protein-coupled receptor (Fig. 6). We envisage the
CTD to function like the suspension system of a road vehicle,
cushioning the influence of obstacles, such as invariant surface
proteins, to allow the NTD to remain unperturbed (Fig. 4a,b).
It is also possible that the VSG deforms on binding of the
host antibodies. IgG and IgM would tether two VSGs and the
NTD—through L1—may bend due to the flow forces during
antibody clearance, while the rest of the CTD ensures the nec-
essary mobility.
Thus, the unique feature of functional importance that sets
VSGs apart from structurally similar proteins31,32 is the pres-
ence and flexibility of its CTD.
This is reflected by the fact that the total width of the VSG
is always determined by the CTD (Fig. 3), which spreads out
furthest towards the surrounding protein coat in our models.
The average width of the M1.1 and I1.24 models is 9.0 nm2
and 10.3 nm2, respectively, and the average area they occupy
for a non-hydrated and static model is 28 nm2 and 30 nm2,
respectively. So, despite a sizable difference, of more than
30%, in the CTD of these two VSGs, the average area that
each VSG spans varies by only 7% (Supplementary Table 3).
However, when considering the rotational freedom between
the CTD and NTD and the high mobile fraction of VSGs on
the cell surface29, the static model obviously underestimates
the actual area each VSG occupies. The consideration of a
highly dynamic VSG molecule results in an extra 20% aver-
age area spanned by I1.24 owing to the increased size of its
CTD. Individual SAXS models display a variance of up to
30% in the area they occupy. This means that different VSGs
can occupy different areas and in turn, the number of VSG
molecules required to cover the cell surface is not constant.
The only experimental analysis with respect to the number
of VSG molecules on the trypanosome cell surface was pub-
lished in 1985 by Jackson et al.25. These authors determined
the number of VSG molecules to be about 5× 106 dimers
per cell. A direct comparison of the VSG molecules per try-
panosome from different experiments is difficult as it has re-
cently become clear that trypanosome morphology is fairly
heterogeneous33, and we therefore present VSG numbers nor-
malized to a defined surface area of 1 µm2. Nevertheless, the
commonly cited 5×106 dimers per cell is in good agreement
with the computed number of M1.1 VSGs based on our SAXS
data.
In summary, VSGs adopt two main conformations that ap-
pear to allow the shielding function to be maintained at vary-
ing protein densities, and also enable a high mobility in the
presence of obstacles and confinement, and protecting recep-
tors from immune detection. This molecular shield is not a
8static barrier, but highly mobile and structurally amazingly
flexible. Beside trypanosomes, many other eukaryotes pos-
sess a GPI-anchored surface coat, not all of which are para-
sites. It would be interesting to see if those cells have evolved
similar structure–function relationships of their major surface
proteins.
Methods
Generation of a transgenic I1.24-expressing cell line. The
open reading frame of VSG I1.24 (IL.24 (UniProt accession
number P26329)) and its 3’-UTR up to and including the con-
served 14-mer sequence was cloned into the EcoRI site of the
M1.2ES targeting vector pKD (ref.34). Following lineariza-
tion with BglII, the construct was integrated into the genome
of a M1.2 expressing T. brucei Lister 427 strain to yield a cell
line that expressed both VSG M1.2 and I1.24. Knockout of
the M1.2 gene by replacement with a puromycin cassette led
to the generation of transgenic cells that expressed I1.24 from
the active M1.2ES.
Purification of sVSG from T. brucei. The VSG is the most
abundantly expressed protein in T. brucei and constitutes 10%
of the total protein35. It can be readily purified directly from
trypanosomes after release by endogenous GPI-specific phos-
pholipase C (GPI-PLC)36,37. T. brucei wild-type strain Lis-
ter 427, which expresses VSG M1.1 (MITat1.1; UniProt ac-
cession number P26331 with amino acid changes K31E and
S65L), or a transgenic Lister 427 cell line that expresses VSG
I1.24 from the M1.2 ES was used to purify the respective
VSGs. Trypanosomes were cultivated in HMI-9 medium38
with 10% fetal bovine serum (Sigma-Aldrich) at 37 ◦C with
5% CO2 using conical flasks agitated on an orbital shaker at
40–80 r.p.m. to allow growth past the conventionally obtained
maximum of 4×106 cells ml−1. Approximately 5×109 cells
were harvested by centrifugation at 5,000g for 30 min at 4 ◦C
and washed in PBS. GPI-anchored proteins were released by
endogenous GPI-PLC after the induction of osmotic shock in
10 mM sodium phosphate buffer, pH 8.0 (ref.36). The hy-
potonic buffer was supplemented with 0.1 mM tosyl-L-lysyl-
chloromethane hydrochloride, 7.5 µM leupeptin and 0.5 µM
aprotinin to protect the sVSG from proteolytic degradation by
cellular proteases. The buffer was changed to 20 mM Tris-
HCl, pH 8.0, using HiTrap desalting columns (GE Health-
care) on an Äktaprime plus (GE Healthcare). Purification
of full-length VSG from the lysate was conducted by anion-
exchange chromatography using HITrapQ HP columns (GE
Healthcare) in 20 mM Tris-HCl, pH 8.0 with a 0–1 M NaCl
gradient. sVSG eluted from the anion-exchange column at ap-
proximately 400 mM NaCl and VSG positive fractions were
pooled. Subsequent purification and removal of the aggre-
gated sVSG was performed by size exclusion chromatography
on a HiLoad 16/600 Superdex 200 pg column (GE Healthcare)
in 20 mM Tris-HCl, pH 8.0, 150 mM NaCl. Fractions that
contained purified protein were pooled again, concentrated
and the buffer was changed to H2O using Amicon Ultra-15
and Ultra-0.5 centricons (Millipore) with a cutoff of 10–30
kDa at 5,000g and 4◦C for 10 min. Purified VSG was flash-
frozen in liquid nitrogen and stored at −20 ◦C. This method
was used to purify VSGs for both macromolecular crystallog-
raphy and SAXS experiments.
Purification of the recombinant M1.1 CTD. For the struc-
tural analysis of the CTD of VSG M1.1 (MITat1.1; UniProt
accession number P26331), a construct was designed to ex-
press residues S372 to S443 of the mature protein. A tobacco
etch virus (TEV) protease recognition site (ENLYFQG) was
added to the open reading frame and cloned into the XhoI
and BamHI sites of pET15b (Novagen) to produce a polypep-
tide with a TEV protease cleavable N-terminal 6×His-tag
(MGSSHHHHHHSSGLVRPGSHMLEENLYFQG). Both an
unlabelled and a 15N-labelled polypeptide were expressed in
Escherichia coli BL21trxB(DE3), grown in 2×TY medium
or minimal medium based on MOPS buffer that contained 5%
15N-labelled Celtone and [15N] ammonium chloride (Spectra
Stable Isotopes), respectively. After cell lysis, the polypeptide
was isolated from the crude protein extract by affinity chro-
matography on a Ni2+ column. The 6×His-tag was subse-
quently removed by digestion with TEV protease to leave an
additional Gly residue at the N-terminus of the M1.1 CTD. Fi-
nal purification was performed by reversed-phase HPLC over
a 25×1 cm Hichrom-5 C8 column in an acetonitrile gradient
in the presence of 0.1% trifluoroacetic acid.
To confirm the protein’s identity and disulfide status, the
relative molecular mass of the unlabelled M1.1 CTD was de-
termined via electrospray ion trap mass spectrometry. The
mass determined for the M1.1 CTD was 8,135.77 Da, which
is in close agreement with the expected mass of 8,135.0 Da for
the fully disulfide-bonded form. Under reducing conditions,
the mass increased to 8,138.87 Da with the expected mass of
the fully reduced polypeptide being 8,139.0 Da.
Crystallization, structure determination and refinement.
Crystal screens were performed using the Honeybee 963 crys-
tallization robot (Zinsser Analytic). Crystal growth could be
observed between 14 and 40 days of incubation using the sit-
ting drop vapour-diffusion method at 20 ◦C with a protein con-
centration of 20 mg ml−1 in H2O mixed in a 1:1 ratio with
0.1 M MES buffer, pH 5.5–6.5, 13–18% poly(ethylene glycol)
(PEG) 20,000. Crystals were cryoprotected by brief incuba-
tion in 0.1 M MES, pH 5.5–6.5, 15–20% PEG 20,000, 25%
glycerol, and subsequently flash-frozen and stored in liquid
nitrogen in CryoLoops (Hampton Research).
Diffraction measurements were conducted at beamline MX
14.1 at the Berliner Elektronenspeicherring-Gesellschaft für
Synchrotronstrahlung (BESSY II), using a PILATUS 6M de-
tector (Dectris) to collect the diffraction data from a single
crystal mounted in a cold nitrogen-gas stream39.
M1.1 crystals were obtained with unit-cell dimensions of
a = 78.5 Å, b = 95.0 Å and c = 103.8 Å in space group
P212121. The crystals diffracted to a resolution of 1.65 Å
(Supplementary Table 1) and contained amino acids A1 to
L368 of the mature protein, which corresponds to the residues
that form the NTD. In accordance with this result, SDS–PAGE
analysis revealed a reduced molecular mass that corresponds
9to 40 kDa for the monomers of the crystallized protein com-
pared with those of the freshly purified sVSG (55 kDa) (Sup-
plementary Fig. 2).
The CCP4 program suite was used for structure solution
and refinement unless otherwise indicated40. Diffraction data
were integrated using iMosflm41 and scaled with Scala42 or
Aimless43. Phasing was carried out by molecular replacement
using the program Phaser44 with the NTD of M1.2 (MITat1.2;
PDB ID: 1VSG), which shares a 27.1% sequence identity with
M1.1, as a search model. The initial automatic model build-
ing was performed using ARP/wARP45 and Buccaneer46, fol-
lowed by manual model building with COOT47 and structure
refinement with REFMAC48.
Structural identities between VSGs were calculated with
UCSF Chimera21, using the Needleman–Wunsch alignment
algorithm49 and a BLOSUM-62 matrix50.
NMR spectroscopy and solution structure determina-
tion. NMR samples of both the unlabelled and 15N-labelled
polypeptide were prepared with the protein at a concentra-
tion of 0.5 mM in 50 mM sodium phosphate, pH 6.0, 150
mM sodium chloride and 10% D2O. Spectra were acquired
at 25◦C on Bruker DRX500, DRX600 and DRX800 spec-
trometers. Experiments performed were double-quantum fil-
tered correlation spectroscopy, total correlation spectroscopy
(TOCSY) (72 ms mixing time), nuclear Overhauser effect
spectroscopy (NOESY) (200 ms mixing time), 15N heteronu-
clear single quantum correlation, 15N-separated TOCSY (72
ms decoupling in the presence of scalar interactions mixing),
15N-separated NOESY (150 ms mixing time) and HNHA.
Spectra were processed with AZARA (W. Boucher) and
analysed with ANSIG51. NOE, dihedral angle (from HNHA)
and hydrogen-bond restraints were generated to yield a to-
tal of 1,008 unambiguous and 257 ambiguous non-degenerate
distance restraints, and structure calculations were performed
with ARIA1.2 (ref.52) interfaced to CNS1.0 (ref.52) using 90
ps of high-temperature dynamics and 30 ps of cooling from
10,000 to 1,000 K in torsion angle space. This was followed
by 24 ps of cooling from 1,000 to 50 K using dynamics in
Cartesian space. In the last iteration, 100 structures were cal-
culated and the 35 lowest-energy structures were used for fur-
ther analysis (Supplementary Table 2).
SAXS and rigid-body modelling of a complete VSG.
SAXS data for VSGs were collected at beamline BM29
(refs53,54) at the European Synchrotron Radiation Facility
(ESRF). Protein serial dilutions were measured utilizing a
concentration range of 0.63–3.14 mg ml−1 for M1.1 and 0.68–
3.39 mg ml−1 for I1.24, and all the samples were mounted by
a robotic sample changer55. The synchrotron beam was col-
limated to 0.7× 0.7 mm at the detector and scattering data
with a q range of 0.025–5 nm−1 were recorded with a PILA-
TUS 1M detector (Dectris) at 293 K at a sample-to-recorder
distance of 2.87 m with an exposure of 10× 1 s (Supple-
mentary Fig. 5 and Supplementary Table 4 give the SAXS
data). The data of each protein series were scaled and extrap-
olated to 0 concentration after subtraction of the buffer using
PRIMUS56. The radius of gyration Rg and the zero-angle scat-
tering intensity I(0) were calculated using AUTORG57 and
data points preceding the Guinier approximation range were
cut from the extrapolated dataset. The pair-distance distribu-
tion function P(r), the maximum particle dimension Dmax and
Rg were calculated using GNOM58 and were consistent with
the estimates from the Guinier approximation. The molec-
ular mass was derived using the Porod invariant on the ex-
cluded volume of the hydrated particle59. Using a scatter-
ing vector of qmax = 3 nm−1 and the previously determined
GNOM files, low-resolution molecular envelopes were con-
structed by averaging ten individual DAMMIN60 models with
imposed P2 symmetry by DAMAVER61. The averaged volu-
metric map was encoded into a pdb file by SITUS vol2pdb62
and used for manual and automated fitting of high-resolution
structural domains in UCSF Chimera and VMD63. Ampli-
tudes for individual high-resolution domains were calculated
by CRYSOL64 without fitting to experimental data to avoid
artefacts from an inaccurate hydration layer. The extrapo-
lated scattering data were used for rigid-body modelling in
BUNCH65 and CORAL59 from the ATSAS software package.
For M1.1, the NTD (residues A1–N367), the structured region
S of the CTD (residues T377–E425) and the GPI anchor at-
tached to the C-terminal residue S443 were modelled into a
spatial relationship, whereas the linkers L1 (residues L368–
Q376) and L2 (residues K426–G442) were computed during
the rigid-body modelling as α-carbon chains. The generated
set of four models showed a good fit to the experimental data
with the discrepancy χ2 ranging from 0.49–1.01. The contact
conditions that were used in the computation of the initial four
models varied slightly by up to 1 Å and the models were cre-
ated using either BUNCH or CORAL. To make sure that the
conformational differences in model 2 are not a result of the
computational differences, consecutive BUNCH iterations of
this model (model 2a in Supplementary Fig. 4a) were calcu-
lated using identical input parameters. The resulting models,
model 2b and model 2c, displayed conformations that closely
resembled models 1–4 in Fig. 3, which emphasizes the ro-
bustness of our system. Models for I1.24 were generated as
described for M1.1 and the four models had a χ2 that ranged
from 1.0 to 1.4.
P2 symmetry was applied to monomers of the individual
domains and initial coordinates were derived from a manual fit
of the domains with the respective vol2pdb map. Contact re-
strictions derived from the N-terminal crystal structures were
applied to preserve the correct dimerization surface between
the monomers in P2. Unstructured parts of the CTD were
removed manually from the pdb files to take the NMR en-
semble source of the C-terminal structure into account and to
increase the number of blanks between structured regions to at
least five residues for correct linker modelling in CORAL. A
maximum scattering vector qmax of up to 3 nm−1 was chosen
individually for each dataset. The GPI anchor was modelled
and attached to the C-terminal amino acid using VMD and
Chimera. The configuration of the S2 domain and the directly
connected GPI in I1.24 were chosen to resemble the config-
uration of previously performed minimizations19 of these re-
gions, whereas the GPI anchor and final C-terminal residue
in M1.1 were treated as individual domains during the mod-
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elling.
Preparation of VSG M1.1 in supported lipid bilayers
for single-molecule imaging. Purification, fluorescence la-
belling and incorporation of the membrane form VSG
(mfVSG) was performed as previously described by Hartel
et al.28. In brief, a crude mfVSG extract from the T. brucei
wild-type strain Lister 427 was obtained using 0.1% trifluo-
roacetic acid (v/v), followed by purification of the membrane
form M1.1 via HPLC. The presence of the intact VSG an-
chor was confirmed by western blotting (10% polyacrylamide
gel, nitrocellulose membrane). The purified protein was la-
belled with Atto-647N NHS-ester (degree of labelling < 0.2).
Small unilamellar vesicles (SUVs) were produced to a con-
centration of 1 mg ml−1 from rehydrated SOPC (1-stearoyl-
2-oleoyl-sn-glycero-3-phosphocholine) (Avanti Polar Lipids))
in vesicle buffer (20 mM Tris-HCl, pH 7.4, 50 mM NaCl and
0.5 mM CaCl2) by sonication or extrusion through polycar-
bonate membranes (50 nm pore size (Whatman)). For the
analysis of the diffusion of lipids, trace amounts of DOPE-488
lipids (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine) were
added to the lipid mix prior to the preparation of the SUVs.
Supported lipid bilayers were formed by fusion of the SUVs
onto cleaned hydrophilic glass slides for 60 min at 37 ◦C. The
membranes were rigorously washed with vesicle buffer to re-
move excess SUVs and ∼ 0.1 pmol of labelled mfVSG M1.1
were subsequently applied onto this lipid bilayer for incorpo-
ration of the lipid moiety of the protein into the outer leaflet.
Successful incorporation was confirmed by microscopy. After
typically 5 min, the membrane was washed to stop the integra-
tion by removing any free protein from the buffer.
Single-molecule imaging. An inverted widefield micro-
scope (Leica DMI6000B) equipped with a high numerical
aperture lens (HCX PL APO 100× /1.47 OIL CORR TIRF)
and an EMCCD camera (pixel size 16 µm (Andor Techno-
logy)) was used for single-molecule imaging. Samples were
illuminated with a 514 nm or 647 nm laser beam (Cobolt) for
10 ms at a mean intensity of 2 kW cm−2 under the control
of an acousto-optic tunable filter (AOTF). The camera-ready
signal triggers a function generator, which sends a rectangu-
lar signal to the AOTF, and thereby specifies the starting point
and duration of the illumination. Fluorescence signals were
detected by the camera using the appropriate filter combina-
tions. Consecutive images (1,000) at the region of interest
(120× 120 pixels) were recorded at T = 24 ◦C and 28 Hz
(∆t = 36 ms). Single fluorescently labelled VSG M1.1 pro-
teins were localized with a precision of 15 nm.
Analysis of single-molecule data. The entire processing of
data was performed in MATLAB R2014a (The MathWorks)
using self-developed scripts. Single Atto-647N molecules
were localized by Gaussian fitting in background-corrected
images66 and filtered with respect to the single-molecule foot-
print of Atto-647N (intensity and width) and detection-error
thresholds. From the remaining single-molecule positions,
trajectories were computed based on a probabilistic algorithm,
as described previously28,66. A total of Nt = 2,969 trajec-
tories of variable length ni (20 ≤ ni ≤ 1263, 〈ni〉 = 49) and
Nt = 1,890 trajectories of variable length ni (9 ≤ ni ≤ 84,
〈ni〉= 13) were extracted for proteins and lipids, respectively.
Each is denoted with an index i, and consists of a sequence of
positions {xi(t j),yi(t j)} recorded at discrete times t j.
To analyse the traces, sequences of squared step length(lij)
2
were constructed by calculating:
(lij)
2 =
(
xi(t j)− xi(t j−1)
)2
+
(
yi(t j)− yi(t j−1)
)2
, (1)
in every time step for each trace. A subset of such unfiltered
sequences is shown in Supplementary Fig. 8a.
Filtering non-Gaussian behaviour. The strong separation in
the characteristic step length is used as a main criterion to
filter this type of motion. Furthermore, as transitions from
and into this slowest behaviour are commonly observed, the
following procedure was adopted. First, the mean step length
〈L2〉 was calculated over the entire set of data:
〈L2〉= 1
∑Nti=1 ni
Nt
∑
i=1
ni
∑
j=1
(lij)
2. (2)
In the second step, a threshold T was set to T = 0.15〈L2〉,
and, from the whole set, all sequences of at least ten succes-
sive steps with a square length smaller than T were extracted.
As a result of such filtering, sequences were obtained that
were either segments of the initial traces or whole trajectories.
In the next step, a new Nt was calculated together with its re-
spective 〈L2〉, and the extraction was repeated. The procedure
was reiterated until the value of 〈L2〉 saturated (to the value of
0.06 µm2 for the current data). The obtained sequences form a
set (black) with a purely exponential distribution of displace-
ments (Supplementary Fig. 9c). Owing to its non-Gaussian
nature, this subclass of trajectories was removed from the cur-
rent analysis. The remaining set (exemplary traces shown in
Fig. 5a) is characterized by 〈L2〉= 〈L2Gauss〉.
Separating the slow and fast diffusion of proteins. Given
that the two remaining populations, denoted as slow and fast
(brown and green, respectively, in Fig. 5a), have significant
overlap, the separation of traces is more delicate. Therefore,
besides thresholding, an additional statistical criterion, based
on the calculation of probability likelihoods, was introduced
in the analysis. Furthermore, as the transitions between the
two populations were not readily observed in this set of data
(most trajectories were significantly shorter than the transition
time between the conformations), the analysis was performed
on the entire traces.
Calculation of likelihoods relies on determining the prob-
ability density P(l2) for observing a particular square step
length l2, and then finding the probability for a given sequence
of step lengths to belong to that distribution—for example, for
each sequence {(li)2} = {(li1)2, . . . ,(lini)2}, the likelihood is
given by the product of probability densities P((lij)
2) to find
all the elements of the sequence in a given distribution. Cal-
culating the ratio of likelihoods to belong to hypothetical dis-
tributions PA and PB:
Ri(PA,PB) =
L
(
PA|{(li)2}
)
L (PB|{(li)2}) =
ni
∏
j=1
PA((lij)
2)
PB((lij)2)
, (3)
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provides a unique criterion to separate two populations.
Namely, Ri = 1 signifies that the probability to belong to both
distributions is the same. On the other hand, Ri > 1 means that
it is Ri times more likely to belong to the distribution PA. In
an analogous way, Ri < 1 suggests that it is 1/Ri more likely
that a sequence belongs to PB than to PA.
To separate the slow and fast diffusion, in the first step each
trace with a mean step length 〈(li)2〉< 23 〈L2Gauss〉= 0.19 µm2
was considered to belong to the population of slowly diffusing
proteins. The remaining sequences were used as the initial set
associated with proteins that exhibited fast diffusion. In the
second step, distributions of square step lengths Pfast(l2) and
Pslow(l2) were constructed. Both distributions showed a sim-
ple exponential behaviour, as expected for simple Gaussian
diffusion, with the fast process having a fourfold larger decay
length. The ratio of likelihoods Ri was extracted for each trace
i, and the traces were reassigned to the appropriate family
(with Ri(Pfast,Pslow) = 1 as the threshold). In the next step, the
probability distributions Pfast and Pslow were re-evaluated and
Ri values recalculated. This step was reiterated until no fur-
ther swaps between families occurred. The converged, purely
exponential distributions are shown in Supplementary Fig. 8b,
and the Gaussian distributions of 1D displacements are shown
in Supplementary Fig. 9a,b.
Comparison with the likelihood that a unique distribution de-
scribes both fast and slow diffusion of proteins. The described
procedure allowed the characterization of each trace i by the
set {〈(li)2〉,Ri}, as shown in Fig. 5b, where the slow and fast
processes are clearly separated into two clusters. Importantly,
the same clustering would take place if the data were sorted
by Ri(Ptotal,Pslow) = 1 as the threshold, where Ptotal signifies
an exponential fit to the entire ensemble of step lengths. This
last finding was consistent with the observation of two distinct
subclasses of trajectories.
Calculation of the mean square displacements. To generate
the distribution of diffusion coefficients Di for each trace, the
mean square displacement MSDi = 〈r2i (t)〉 was calculated as
a function of time:
MSDi =
1
ni− t/∆t
ni−t/∆t
∑
j=1
[(
xi(t j + t)− xi(t j)
)2
+
(
yi(t j + t)− yi(t j)
)2]
(4)
= 4Dit. (5)
Here t is a discrete time defined as t = N∆t, where N ∈ N.
Owing to the limited size of each trajectory only the first three
points were considered statistically relevant and used for lin-
ear regression, with Di being a fit parameter. The distribution
of Di is shown for both families of traces in Fig. 5c.
A more-detailed analysis of the properties of the distribu-
tion allowed the calculation of the mean 〈D〉, standard devia-
tion σD and standard error SED:
〈D〉= 1
Nt
Nt
∑
i=1
Di, (6)
σD =
√√√√ 1
Nt
Nt
∑
i=1
(Di−〈D〉)2, (7)
SED =
√
σD
Nt
. (8)
Analogous results (shown in the inset of Fig. 5c) were ob-
tained by calculating the time-averaged MSD on the cumula-
tive trajectory for each population. The latter was constructed
by concatenating all the trajectories that belonged to a popula-
tion and creating a single long trace of length Nc. In this case,
the MSD was calculated as
MSD =
1
Nc− t/∆t
Nc−t/∆t
∑
j=1
[
(x(t j + t)− x(t j))2
+(y(t j + t)− y(t j))2
]
(9)
= 4Dt. (10)
Data availability. Structure information for the NTD and
CTD of VSG M1.1 have been deposited in the RCSB Pro-
tein Data Bank with the accession codes PDB 5LY9 and PDB
5M4T, respectively. Other data that support the findings of
this study are available on request.
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